Test Price
2,800 AED✅ Home Collection Available
CAPN1 Gene Sequencing (Muscular-Skeletal Disorders) – Genetic Test in UAE | 2,800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation by DHA‑licensed Consultant Medical Genetics.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This NGS‑based CAPN1 genetic test screens the entire coding region of the CAPN1 gene for pathogenic variants linked to hereditary spastic paraplegia, limb‑girdle muscular dystrophy and other neuromuscular disorders. Our platform combines targeted enrichment with Sanger validation to ensure >99% sensitivity for single nucleotide variants, small insertions/deletions, and copy number variations.
| Feature | Our Test (NGS) | Conventional Sanger CAPN1 Sequencing |
|---|---|---|
| Precision | >99% sensitivity for SNVs, indels & CNVs | ~95% per exon; may miss large deletions |
| Method | Next‑Generation Sequencing + Sanger validation | Stepwise Sanger (one exon at a time) |
| Turnaround | 3–4 Weeks | 5–6 Weeks |
Physician Insight & Safety Protocols
"As a Consultant Medical Genetics at DNA Labs UAE, I emphasize that CAPN1 gene sequencing provides high diagnostic accuracy for hereditary spastic paraplegia and limb‑girdle muscular dystrophy. However, results must be correlated with clinical findings and family history. A negative result does not rule out disease, and a positive result requires genetic counseling. – Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403"
Pre-Test Advisory
- Prior genetic counseling is strongly recommended to ensure informed consent and appropriate test selection.
- Provide a complete clinical history, including family pedigree and prior neurological examinations.
- This test is intended for diagnostic confirmation of suspected CAPN1‑related disorders; it is not a population screening tool.
Exclusion Criteria & Safety Notices
- This test is not for individuals without a clinical suspicion of a CAPN1‑related disorder or who have not received prior genetic counseling.
- If you are experiencing acute neurological symptoms – such as sudden paralysis, severe muscle spasms, or breathing difficulty – do not rely on this home collection service. Seek emergency care immediately.
- Minors under 18 years require a parent/guardian’s consent in accordance with Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- Failure to provide a complete clinical history and a prior genetic counseling referral may delay or invalidate the test.
- Emergency red flags: Acute loss of motor function, inability to swallow, sudden vision changes, confusion or loss of consciousness – go directly to the nearest ER.
Patient FAQ & Clinical Guidance
1. What does the CAPN1 gene test diagnose?
This Genetic Test detects pathogenic variants in the CAPN1 gene responsible for hereditary spastic paraplegia type 76, limb‑girdle muscular dystrophy, and related neuromuscular disorders with >99% diagnostic sensitivity.
2. How is the sample collected and what is the turnaround time?
A blood sample is collected via a painless home phlebotomy service, and DNA is extracted; results are reported within 3 to 4 weeks using state‑of‑the‑art NGS plus Sanger validation.
3. Is this covered by UAE health insurance?
Many UAE insurers cover CAPN1 gene testing when prior authorization is obtained; our team verifies coverage and assists with direct billing via WhatsApp at +971 54 548 8731.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License No. 1143 and is fully compliant with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is encrypted, access‑controlled, and processed exclusively within accredited UAE facilities. Patients retain full rights to access, rectify, or request deletion of their data as per PDPL provisions.
Clinical & Logistical Metadata
| Test Name | CAPN1 Gene Sequencing |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood – VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (Available daily from 8 AM to 11 PM) |
| Methodology Used | Next‑Generation Sequencing (NGS) with Sanger Confirmation |
| ICD-10-CM Code | G71.0, G11.4 |
| LOINC Code | 21613-4 |
| DHA Facility License & Laboratory Address | DHA License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians